RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

DiaMonTech D-Pocket (blood glucose system)

Product
Developers: DiaMonTech
Date of the premiere of the system: February 2022
Branches: Pharmaceuticals, medicine, healthcare

2022: System Announcement

On February 18, 2022, DiaMonTech introduced a patented technology platform operating in the middle infrared range and allowing for non-invasive measurement of blood glucose using painless laser detection. According to representatives of the company, the ease of using the platform is comparable to a fingerprint sensor on a smartphone, as well as experts strive to ensure that the platform allows controlling blood glucose levels without finger pricks and test strips.

DiaMonTech offers a smartphone-like portable D-Pocket device for tracking blood sugar anywhere. The company also has a base station (for home use) and a wearable device for continuous glucose measurement.

D-Pocket (blood glucose determination system)

In February 2022, DiaMonTech attracted $5 million in investments, as a result of which the total financing of the startup exceeded $20 million. According to the press release, the company plans to use the investment to accelerate the development of its products and expand business in the world. Samsung Ventures, as well as an unnamed global medical technology company, joined the project as strategic partners, which DiaMonTech officials say confirms its ambition to make a wave in non-invasive diabetes management.

File:Aquote1.png
We are pleased to welcome Samsung Ventures as a strategic partner in this round of funding alongside Unorthodox Ventures, Golden Light and existing shareholders of IBB Ventures. Our investors supported a whole wave of revolutionary technology companies. Their support for DiaMonTech is a vote of confidence in our team and technology, "said DiaMonTech CEO Thorsten Lubinski.
File:Aquote2.png

The quality of diabetes compensation in a patient receiving insulin therapy directly depends on the frequency of blood glucose measurements. During basic bolus insulin therapy, blood glucose levels should be measured:

  • Before administration of short insulin;
  • 1-1.5 hours after breakfast, lunch and dinner;
  • At the peak of each dose of short insulin;
  • Before bed.[1]

Notes